Ocular Therapeutix, Inc. (NASDAQ: OCUL, "Ocular”), an integrated biopharmaceutical company committed to redefining the retina ...

The granted patent provides protection for the use of PrimeC combination in Alzheimer's disease, strengthening NeuroSense's intellectual property estate and supporting the program's long-term ...

Ocular Therapeutixtm Appoints David W. Robinson As Global Chief Commercial Officer. Accomplished global commercial leader with deep expertise in retina drug launches Primary architect for the industry ...

Doseology Sciences Inc. ("Doseology" or the "Company") a leader in biotechnology-driven consumer products, today announced the initiation of a pilot production run of non-nicotine, caffeine-based ...

Accomplished global commercial leader with deep expertise in retina drug launches Primary architect for the industry-defining launch of EYLEA- while at Regeneron Most recently served as Chief Marketin ...

Stability is a critical factor in drug formulation, with implications for product quality, lifecycle management, and ...

Metastatic urothelial carcinoma has a poor prognosis: ~50% of muscle-invasive bladder cancer progresses to metastasis, and ...

What you need to know: Titleist introduces two new balls in the non-Pro V1 category with the completely redesigned Tour Soft ...

Maui Grown Remedies, a Hawai' i-based wellness company known for high-performance, plant-based formulations trusted by ...

CDMOs are expanding to provide integrated services, enhancing outsourcing appeal. Sustainability mandates boost adoption of advanced systems, and growth is pronounced in excipient innovation and ...

By Michael Erman and Christy Santhosh Jan 20 (Reuters) - Novavax said on Tuesday it signed a licensing agreement allowing ...

New sublingual delivery system designed to enhance bioavailability and speed of onset for major depressive and ...